StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a report issued on Wednesday morning. The brokerage issued a sell rating on the medical research company’s stock.
Organovo Price Performance
Shares of ONVO stock opened at $0.47 on Wednesday. The stock’s fifty day moving average price is $0.54 and its 200 day moving average price is $0.79. Organovo has a 1-year low of $0.43 and a 1-year high of $2.05. The company has a market cap of $6.70 million, a price-to-earnings ratio of -0.29 and a beta of 0.62.
Organovo (NASDAQ:ONVO – Get Free Report) last posted its quarterly earnings data on Monday, August 5th. The medical research company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.38) by $0.15. The company had revenue of $0.04 million for the quarter, compared to analyst estimates of $0.03 million. As a group, equities research analysts anticipate that Organovo will post -0.96 earnings per share for the current year.
Institutional Inflows and Outflows
Organovo Company Profile
Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
Further Reading
- Five stocks we like better than Organovo
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Market Cap Calculator: How to Calculate Market Cap
- MarketBeat Week in Review – 9/30 – 10/4
- 3 Small Caps With Big Return Potential
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.